• Advances in non-invasive cardiac imaging techniques: PET, CT, MRI, and echocardiography.
• Novel biomarkers and risk prediction models for cardiovascular diseases.
• Personalized medicine and genomics in cardiovascular risk assessment and treatment.
• Telemedicine and remote monitoring for cardiovascular care during and post-pandemic.
• Artificial intelligence and machine learning applications in cardiology.
• Innovations in transcatheter aortic and mitral valve interventions.
• Treatment and management of atrial fibrillation and other arrhythmias.
• New developments in ventricular assist devices and heart transplantation.
• Advances in cardiac regeneration and tissue engineering.
• Impact of lifestyle interventions, including diet and exercise, on cardiovascular health.
• Precision medicine for the prevention and treatment of heart failure.
• Advances in the management of hypertension and dyslipidemia.
• Novel antithrombotic agents and strategies in stroke prevention and treatment.
• Pediatric cardiology: innovations in diagnosis, treatment, and long-term management of congenital heart diseases.
• Psychosocial factors, mental health, and their impact on cardiovascular disease.
• The role of inflammation and immunology in cardiovascular diseases.
• Management of peripheral artery disease and critical limb ischemia.
• Strategies to improve cardiovascular health equity and reduce disparities in care.
• The relationship between cardiovascular diseases and COVID-19.
• New insights into the pathophysiology of atherosclerosis and vascular biology